N@N

QUOT, FNSR, MYGN, OMCL, CRY, PRU, Expected to Trade Lower After Bearish Insider Trading

^{Published on 2016-09-14 05:45:23 - WOPRAI}
 

September 14, 2016 / M2 PRESSWIRE / BUYINS.NET / http://www.squeezetrigger.com is monitoring top insider trading patterns and these stocks are the most likely to trade Lower in the next 6 months. Quotient Technology Inc. (NYSE:QUOT), Finisar Corporation (NASDAQ:FNSR), Myriad Genetics Inc. (NASDAQ:MYGN), Omnicell, Inc. (NASDAQ:OMCL), CryoLife Inc. (NYSE:CRY), Prudential Financial Inc. (NYSE:PRU) are all expected to go Lower as Sell signals have been generated by top insider trading patterns. The most important data elements considered when performing insider analysis are: Insiders Track Record - An insiders track record is best summarized by the Insider Score which ranges from 1 (least predictive) to 100 (most predictive) based on prior trading performance. In addition, the actual returns following the insiders prior trades are included to determine the potential magnitude of future returns. Insiders Role - Trades by higher-level insiders are generally more predictive than trades by lower level insiders. Higher-level insiders to include Chairman (CB), Chief Executive Officer (CEO), President (P), Chief Financial Officer (CFO), and Vice Chairman (VC).

The chart below displays the stocks expected to go Lower along with the insider name, position, predictive insider score, 6 month expected return and number of trading decisions included in the score.

  Symbol  Company Name                     Insider Name                     Role     Shares      Insider Score  Avg 6 Month Return  # of Dec. 
  QUOT    Quotient Technology Inc.         Lepore, Dawn Gould               D        4,000       91             -27.3%              3         
  FNSR    Finisar Corporation              Brown, Christopher E             O        2,470       99             -15.1%              21        
  MYGN    Myriad Genetics Inc.             Henderson, John Tannahill        D        30,000      76             -5.5%               4         
  OMCL    Omnicell, Inc.                   Petersmeyer, Gary S              D        2,000       75             -4.0%               36        
  CRY     CryoLife Inc.                    Lee, David Ashley                CO       31,833      93             -11.3%              11        
  PRU     Prudential Financial Inc.        Taylor, Sharon C.                O        13,039      88             -7.8%               5         

Quotient Technology Inc. (NYSE:QUOT) - Quotient Technology Inc. provides digital promotions and analytics platform that connect brands and retailers with consumers in the United States. It offers digital coupons, including coupons and coupon codes, and media and advertising through its platform, which includes mobile, Web, and social channels, as well as consumer packaged goods (CPGs), retailers, and publishers. The company s CPG customers comprise food, beverage, drug, personal, and household product manufacturers; and retailers consist of grocery, drug, dollar, club, and mass merchandise channel retailers, as well as clothing, electronics, home improvement, and other stores. The company was formerly known as Coupons.com Incorporated and changed its name to Quotient Technology Inc. in October 2015. Quotient Technology Inc. was founded in 1998 and is headquartered in Mountain View, California..

Finisar Corporation (NASDAQ:FNSR) - Finisar Corporation provides optical subsystems and components for data communication and telecommunication applications in the United States, Malaysia, China, and internationally. Its optical subsystems primarily consist of transmitters, receivers, transceivers, transponders, and active optical cables that provide the fundamental optical-electrical or optoelectronic interface for interconnecting the electronic equipment used in communication networks, including the switches, routers, and servers used in wireline networks, as well as the antennas and base stations used in wireless networks. The company also offers wavelength selective switches, which are used to switch network traffic from one optical fiber to multiple other fibers without converting to an electronic signal. In addition, it provides optical components comprising packaged lasers, receivers, and photodetectors for data communication and telecommunication applications; and passive optical components for telecommunication applications. Finisar Corporation markets its products through its direct sales force, as well as through a network of distributors and manufacturers representatives to the original equipment manufacturers of storage systems, networking equipment, and telecommunication equipment, as well as to their contract manufacturers. Finisar Corporation was founded in 1987 and is headquartered in Sunnyvale, California..

Myriad Genetics Inc. (NASDAQ:MYGN) - Myriad Genetics, Inc., a personalized medicine company, focuses on the development and marketing of predictive, personalized, and prognostic medicine tests worldwide. It operates through two segments, Diagnostics and Other. The Diagnostics segment primarily provides testing and collaborative development of testing that is designed to assess an individual s risk for developing disease; identify a patient s likelihood of responding to drug therapy; guide a patient s dosing to ensure optimal treatment; and assess a patient s risk of disease progression and disease recurrence. The Other segment provides testing products and services to the pharmaceutical, biotechnology, and medical research industries; and research and development, and clinical services for patients. Its molecular diagnostic DNA sequencing tests include myRisk Hereditary cancer, a test for hereditary cancers; BRACAnalysis and BART, which are tests for hereditary breast and ovarian cancers; BRACAnalysis CDx test for use in identifying ovarian cancer patients with suspected deleterious germline; and Tumor BRACAnalysis CDx test that is used to predict DNA damaging agents, such as platinum based chemotherapy agents and poly ADP ribose inhibitors. The company also provides COLARIS test for colorectal and uterine cancers; COLARIS AP test for colorectal cancer; Vectra DA protein detection test for assessing the disease activity of rheumatoid arthritis; Prolaris, a RNA expression test for prostate cancer; EndoPredict RNA expression test for breast cancer; myPath Melanoma RNA expression test for diagnosing melanoma; myChoice homologous recombination deficiency (HRD) test to measure three modes of HRD; and myPlan lung cancer, an RNA expression test for lung cancer. Myriad Genetics, Inc. has collaboration with AstraZeneca for the development of an indication for BRACAnalysis CDx. The company was founded in 1991 and is headquartered in Salt Lake City, Utah..

Omnicell, Inc. (NASDAQ:OMCL) - Omnicell, Inc. provides automation and business analytics software solutions for medication and supply management in healthcare worldwide. The company operates through two segments, Automation and Analytics, and Medication Adherence. It offers OmniRx, a dispensing system that automates the management and dispensing of medications at the point of use; SinglePointe, a software product that controls medications; AnywhereRN, that remotely queue automated dispensing cabinets; Pandora Analytics, a reporting and data analytics tool; and Savvy Mobile System, which provides a platform for hospital information systems. The company also provides OmniLinkRx, a prescription routing system; WorkflowRx, an automated pharmacy storage, retrieval, and packaging system; Central Pharmacy and Satellite Pharmacy Manager, an automated pharmacy storage and retrieval system; Controlled Substance Management, a controlled substance inventory management system; and Anesthesia Workstation that manages anesthesia supplies and medications. In addition, it offers Omnicell Supply Solution, which automates the management and dispensing of medical and surgical supplies; Omnicell Open Supply Solution for inventory management; Supply/Rx Combination Solution for managing supplies and medications; Omnicell Tissue Center that manages the chain of custody for bone and tissue specimens; OptiFlex SS, a module for the perioperative areas; OptiFlex CL, a module for the cardiac catheterization lab and other procedure areas; and OptiFlex MS, a system for managing medical and surgical supplies. Further, Omnicell, Inc. offers Central Pharmacy, Point of Care, and IV Solutions; software; and consumable medication blister cards, packaging equipment, and ancillary products and services to institutional pharmacies. The company was formerly known as Omnicell Technologies, Inc. and changed its name to Omnicell, Inc. in 2001. Omnicell, Inc. was founded in 1992 and is headquartered in Mountain View, California..

CryoLife Inc. (NYSE:CRY) - CryoLife, Inc., together with its subsidiaries, manufactures and distributes medical devices worldwide. It also processes and distributes implantable human tissues for use in cardiac and vascular surgeries. The company operates in two segments, Medical Devices and Preservation Services. It offers surgical sealants and hemostats, including BioGlue Surgical Adhesive, an agent for cross-linking proteins for cardiac, vascular, pulmonary, and general surgical applications; BioFoam Surgical Matrix, which is used as an adjunct in sealing abdominal parenchymal tissues, as well as an adjunct for hemostasis in cardiovascular surgery; and PerClot, an absorbable powdered hemostat for use in surgical procedures, including cardiac, vascular, orthopedic, neurological, gynecological, ENT, and trauma surgeries. The company also provides cardiac laser therapy products, which include laser console system and single-use, as well as fiber-optic hand-pieces for the treatment of coronary artery disease in patients with severe angina; and On-X heart valves for aortic and mitral indications. In addition, it distributes ProCol vascular bioprosthesis, a biological graft that provides vascular access for end-stage renal disease in hemodialysis patients; and PhotoFix, a bovine pericardial patch for use in cardiac and vascular repairing activities. Further, it distributes CryoValve SG pulmonary heart valves and CryoPatch SG pulmonary cardiac patch tissues that are processed using its proprietary SynerGraft technology; and vascular preservation services, such as CryoVein and CryoArtery tissues to treat various vascular reconstructions, such as peripheral bypass, hemodialysis access, and aortic infections. The company serves physicians, hospitals, and other healthcare facilities, as well as cardiac, vascular, thoracic, and general surgeons. CryoLife, Inc. was founded in 1984 and is headquartered in Kennesaw, Georgia..

Prudential Financial Inc. (NYSE:PRU) - Prudential Financial, Inc., through its subsidiaries, provides insurance, investment management, and other financial products and services in the United States and internationally. It offers primarily life insurance, annuities, retirement-related, mutual funds, and investment management products and services. The company operates through U.S. Retirement Solutions and Investment Management, U.S. Individual Life and Group Insurance, and International Insurance divisions. The U.S. Retirement Solutions and Investment Management division provides individual variable and fixed annuity products; and recordkeeping, plan administration, actuarial advisory, tailored participant education and communication, trustee, and institutional and retail investment services. It also offers brokerage services; guaranteed investment contracts, funding agreements, structured settlement annuities, and other group annuities; and investment management and advisory services to the public and private marketplace. The U.S. Individual Life and Group Insurance division provides individual variable, term, and universal life insurance products to mass middle, mass affluent, and affluent markets; group life; long-term and short-term group disability; and group corporate, bank, and trust-owned life insurance products to institutional clients. It also sells accidental death and dismemberment, and other ancillary coverages; and offers plan administrative services. The International Insurance division provides individual life insurance, retirement, and related products. The company serves individual and institutional customers through third-party broker-dealers, independent financial planners, financial professionals, third-party financial advisors, brokers, benefits consultants, sales force, wire houses, banks, general agencies, producer groups, life planners, and life consultants. Prudential Financial, Inc. was founded in 1875 and is headquartered in Newark, New Jersey..

About BUYINS.NET

BUYINS.NET, http://www.buyins.net, monitors trading in all US stocks in real time and maintains massive databases of short sale and naked short sale time and sales data, short squeeze SqueezeTrigger prices, market-maker price movements, shareholder data, statistical data on earnings, sector correlation, seasonality, hedge fund trading strategies, comparable valuations. Reports include:

REGULATORY & COMPLIANCE NEWS Friction Factor - Market maker surveillance system tracking Level II market makers in all stocks to determine Price Friction and compliance with new "Fair Market Making Requirements" Naked Shorts (RegSho) - Tracks EVERY failure to deliver in all US stocks and tracks all Threshold Security Lists daily for which stocks have naked shorts that are not in compliance with Regulation SHO

INVESTMENTS & TRADING Earnings - Predicts probability, price move and length of move before and after all US stock earnings reports Seasonality - Predicts probability, price move and length of move based on exact time of year for all US stocks Group Correlation - Tracks sector rotation and stock correlation to its sector and predicts future moves in ALL sectors and industry groups SqueezeTrigger - Massive database that tracks EVERY short sale (not just total short interest) in all US stocks and calculates volume weighted price that a short squeeze will begin in each stock. Valuation - Tracks all known valuation models and applies them. GATS - Tracks and quantifies known trading strategies by backtesting, optimizing and running genetic algorithms and neural networks to ascertain best trading strategies. PatternScan - Automates tracking of every technical pattern and predicts next move in stocks. Insider - Tracks insiders trading records and determines trading performance. Trades by higher-level insiders are generally more predictive than trades by lower level insiders Events - Tracks patterns directly correlated to specific events.

SqueezeTrigger is a registered trademark, Reg. No. 3,120,641

DISCLAIMER:

BUYINS.NET is not a registered investment advisor and nothing contained in any materials should be construed as a recommendation to buy or sell any securities. [symbol] has not approved the statements made in this release. Please read our report and visit our web site, http://www.buyins.net, for complete risks and disclosures.

Contact: BUYINS.NET Thomas Ronk 800-715-9999 tom@buyins.net http://www.buyins.net